IBIO · iBio Inc
United States · RS rating 10 · As of 2026-11-03
| Price | 0.82 USD |
|---|---|
| 1-day change | +2.9% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 15 / 13 / 22 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 6 / 41 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +18.2% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +73.2% |
| Market cap (USD) | $65.4M |